The Sinus Dilation Devices Market, estimated at USD 4.56 Bn in 2026, is expected to exhibit a CAGR of 11.2% and reach USD 7.89 Bn by 2033.
Global Sinus Dilation Devices Market, by Product Type (Balloon Sinuplasty Systems Rhinoscopes, Sinuscopes, Sinus Stents, Functional Endoscopic Sinus Surgery (FESS) Instruments Set, and Others), by End User (Hospitals & Clinics and Ambulatory Surgical Centers (ASCs)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at USD 7.89 Bn in 2033, and is projected to exhibit a CAGR of 11.2 % over the forecast period (2026 – 2033).
Sinusitis is an inflammation of sinus, which causes nose blockage and avoids mucus drainage. Sinus dilation devices are used in patients with nose drainage issues related to nasal sinusitis or sinuses to expand the sinus openings. Different types of sinus dilation devices includes balloon sinuplasty systems, rhinoscopes, sinus stents, and functional endoscopic sinus surgery (FESS), and instruments set for sinuses or sinusitis New launches of sinus dilation devices by market players augment growth of the market. Key players in the market are focused on launching novel catheters in order to reduce nasal sinusitis or sinuses and address the critical unmet needs of patients. For instance, in January 2014, Acclarent Inc. launched a new range of Balloon Sinuplasty System, RELIEVA, in the U.S. for the treatment of chronic sinusitis in children. This will help the company to diverge its portfolio for various age groups. Similarly, in June 2015, SinuSys Corporation received CE mark for its two new devices to treat frontal and sphenoid sinusitis, in addition to maxillary disease. This will help the company to expand its product portfolio of low-pressure and self-expanding dilation devices.
Browse 36 Market Data Tables and 32 Figures spread through 164 Pages and in-depth TOC on ‘Sinus Dilation Devices Market’- Global Forecast to 2033, by Product Type (Balloon Sinuplasty Systems Rhinoscopes, Sinuscopes, Sinus Stents, Functional Endoscopic Sinus Surgery (FESS) Instruments Set, Others), by End User (Hospitals & Clinics, Ambulatory Surgical Centers (ASCs)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) To know the latest trends and insights prevalent in the sinus dilation devices market, click the link below: https://www.coherentmarketinsights.com/market-insight/sinus-dilation-devices-market-2451 Key players are focusing on adopting various business strategies such as mergers and acquisitions to enhance its product portfolio. For instance, Stryker Corporation completed the acquisition of Entellus Medical Inc. in February 2018. Through this acquisition, Stryker Corporation would promote products of Entellus Medical Inc.
Key News
- In June 2026, Medtronic plc, medical device company received CE Mark approval for its Stealth AXiS surgical system, marking a major milestone in advancing image-guided, robotic-enabled surgery across Europe. The system integrates surgical planning, navigation, and robotics into a single connected platform, enhancing precision in ENT, spine, and cranial procedures. Built within the AiBLE ecosystem, it supports real-time guidance and workflow efficiency, enabling surgeons to perform complex minimally invasive procedures with improved accuracy and clinical confidence. (Source: Medtronic plc)
- In December 2025, Airiver Medical, a clinical stage company innovating technologies secured FDA Investigational Device Exemption (IDE) approval to initiate a pivotal clinical study of its drug-coated balloon for treating chronic rhinosinusitis (CRS). The RESTORE-2 trial will evaluate a minimally invasive approach combining balloon dilation with localized drug delivery to improve long-term sinus drainage and reduce recurrence of symptoms. The study aims to generate clinical evidence supporting safety and efficacy, potentially offering CRS patients improved outcomes and fewer repeat surgical interventions. (Source: Airiver Medical)
Key Takeaways of the Sinus Dilation Devices Market
- The global sinus dilation devices market is expected to exhibit a CAGR of 11.2% over the forecast period, owing to increasing prevalence of chronic sinusitis
- Among product type, the balloon sinuplasty systems segment held a dominant position in the sinus dilation devices market in 2026 owing to higher adoption rate for sinusitis treatment.
- Among end user, hospitals and clinics segment held a dominant position in the sinus dilation devices in 2026. This is attributed to the fact that the number of patients visiting hospital and clinical settings is higher as compared to ambulatory surgical centers.
- Key players operating in the global sinus dilation devices market include, Entellus Medical, Inc., Smith & Nephew Plc., Acclarent, Inc., B. Braun Melsungen AG, Medtronic Plc, Olympus Corporation, SinuSys Corporation, InnAccel Technologies, Intersect ENT, Inc.
Contact Us